TABLE 1.
Cross | Donor allele | Recipient allele | Line no. | No. recb | Exon 1 markers
|
Exon 2 markers
|
Exon 3 markers
|
Type event | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
E1−387 [Hpa+, Hpa−] | E1−20 [T, A] | E1−11 [G, A] | E1−6 [T, A] | E2−27 [T, C] | E2−8 [G, A] | E2−5 [T, (C)] | E2−2 [C, (T)] | E3+2 [C, (T)] | E3+5 [A, (G)] | E3+8 [A, (G)] | E3+23 [T, A] | ||||||
A1 | 1o2+, wild-type | 1o2o, Scap | 1 | 2 | D | D | D | D | D | D | * | * | * | * | * | R | RNA |
2 | 5 | R | D | D | D | D | D | * | * | * | * | * | R | RNA | |||
3 | 2 | D | D | D | D | D | D | * | * | * | * | * | D | DNA | |||
4 | 2 | R | D | D | D | D | D | * | * | * | * | * | D | DNA | |||
A2 | 1o2YAAA, RT mutant | 1o2o, Scap | 5 | 2 | D | D | D | D | D | D | * | * | * | * | * | D | DNA |
6 | 7 | R | D | D | D | D | D | * | * | * | * | * | D | DNA | |||
7 | 1 | R | R | R | R | R | D | * | * | * | * | * | R | DNA | |||
B | 1o2+, wild-type | 1o2o, E3+5G | 8 | 3 | D | D | D | D | D | D | * | * | * | R | * | R | RNA |
9 | 6 | R | D | D | D | D | D | * | * | * | R | * | R | RNA | |||
10 | 3 | D | D | D | D | D | D | * | * | * | D | * | D | DNA | |||
11 | 8 | R | D | D | D | D | D | * | * | * | D | * | D | DNA | |||
C | 1o2+, wild-type | 1o2o, E3+8G | 12 | 6 | R | D | D | D | D | D | * | * | * | * | R | R | RNA |
13 | 2 | R | R | D | D | D | D | * | * | * | * | R | R | RNA | |||
14 | 2 | D | D | D | D | D | D | * | * | * | * | D | D | DNA | |||
15 | 7 | R | D | D | D | D | D | * | * | * | * | D | D | DNA | |||
16 | 1 | R | R | R | R | R | R | * | * | * | * | D | D | DNA | |||
17 | 1 | R | D | D | D | D | D | * | * | * | * | D | R | DNA | |||
D | 1o2+, wild-type | 1o2o, E2−2T−5C E3+2T+5G | 18 | 4 | D | D | D | D | D | D | D | D | R | R | * | R | RNA |
19 | 14 | R | D | D | D | D | D | D | D | R | R | * | R | RNA | |||
20 | 1 | R | R | D | D | D | D | D | D | R | R | * | R | RNA | |||
21 | 2 | R | R | R | R | D | D | D | D | R | R | * | R | RNA | |||
22 | 10 | D | D | D | D | D | D | D | D | D | D | * | D | DNA | |||
23 | 7 | R | D | D | D | D | D | D | D | D | D | * | D | DNA | |||
24 | 1 | R | R | D | D | D | D | D | D | D | D | * | D | DNA | |||
25 | 1 | R | D | D | D | D | D | D | D | D | D | * | R | DNA |
Recombinant progeny were isolated from each cross as described in Materials and Methods. For each recombinant strain the exons flanking the aI2 insertion site were sequenced so that all of the flanking markers present in each cross were scored (see also Fig. 1). The nucleotide present at each site in donor and recipient strains is shown in brackets above each column as follows: [donor, recipient]. Alleles in parentheses are present only in some of the recipient strains, as indicated. Asterisks indicate that the donor and recipient strains in that cross have the same nucleotide. For each cross, results are organized according to the type of event that likely led to each coconversion pattern. Coconversion tracts are indicated in boldface type. In the type event column, “RNA” denotes the products of retrohoming, while “DNA” denotes the products of RT-independent homing. The rationale for these assignments is presented in the text. Figure 5 illustrates some of these patterns schematically. D, donor allele (intron insertion was accompanied by coconversion at that site); R, recipient allele (intron insertion was not accompanied by coconversion at that site).
No. rec, number of recombinant progeny analyzed for flanking markers.